SAIL Fusion
Private Company
Funding information not available
Overview
SAIL Fusion is a private, commercial-stage medical device company addressing the significant unmet need in sacroiliac joint fusion. Founded in 2015 and based in Carlsbad, California, the company has developed the BowTie SI Fusion System, which applies proven orthopedic fusion principles to the SI joint via a uniquely shaped implant. Led by a seasoned executive team with deep experience in spine and orthopedics, the company is positioned to capture share in a growing market, though it faces competition from established players and must navigate the challenges of commercial adoption and potential regulatory scrutiny.
Technology Platform
The BowTie SI Fusion System, an implant system applying AO Foundation joint fusion principles (minimal tissue disruption, thorough joint preparation, rigid fixation) specifically to the sacroiliac joint via a bowtie-shaped implant for multi-planar stability.
Opportunities
Risk Factors
Competitive Landscape
The SI joint fusion market is competitive, dominated by players like SI-BONE (pioneer with the iFuse system), Medtronic, Globus Medical, and ZimVie. Competitors employ various technologies including percutaneous screws and triangular implants. SAIL Fusion differentiates by emphasizing the application of foundational AO fusion principles and the unique biomechanical stability of its bowtie implant.